[EN] PYRIDOPYRIMIDINEDIONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDOPYRIMIDINEDIONE
申请人:NOVARTIS AG
公开号:WO2015186061A1
公开(公告)日:2015-12-10
The invention relates to compound of the formula (I) or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
quinazoline alkaloid isolated from Dichroa febrifuga roots, shows powerful antimalarial activity against Plasmodium falciparum. Although the use of ferifugine as an antimalarial drug has been precluded because of its severe side effects, its potent antimalarial activity has stimulated medicinal chemists to pursue its derivatives instead, which may provide valuable leads for novel antimalarial drugs. In
[6,7]-propylene-, -butylene- or -pentylene-fused imidazopyridin-4-amines that induce interferon (.alpha.) biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon (.alpha.) biosynthesis and treating viral infections involving the use of such compounds.
(EN) 6,7-Propylene-, butylene-, or pentylene-bridged imidazopyridin-4-amines of formula (I) that induce interferon ($g(a)) biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon ($g(a)) biosynthesis and treating viral infections involving the use of such compounds.(FR) L'invention concerne des imidazopyridin-4-amines avec un pont 6,7-propylène, butylène ou pentylène, représentées par la formule (I), qui induisent la biosynthèse de l'interféron ($g(a)) dans des cellules humaines. On décrit également des compositions pharmaceutiques contenant de tels composés et des procédés pour induire la biosynthèse de l'interféron ($g(a)), ainsi que l'utilisation de tels composés dans le traitement d'infections virales.
Fused cycloalkylimidazopyridines as inducer of interferon .alpha.
申请人:Minnesota Mining and Manufacturing Company
公开号:US05444065A1
公开(公告)日:1995-08-22
6,7-propylene-, butylene-, or pentylene-bridged imidazopyridin-4-amines that induce interferon (.alpha.) biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon (.alpha.) biosynthesis and treating viral infections involving the use of such compounds.